← Eichor
Condition: Hes Hypereosinophilic Syndrome Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hes Hypereosinophilic Syndrome

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Predictive Signature of Benralizumab Response
Phase 4 · 20 location(s) · Nantes University Hospital · NCT04565483A Non-interventional, Prospective Study With Benralizumab
Phase N/A · 41 location(s) · AstraZeneca · NCT06422078Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Charact
Phase N/A · 1 location(s) · Medical University Innsbruck · NCT04538937A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Phase 2 · 58 location(s) · Kymera Therapeutics, Inc. · NCT07323654Natural History of Hypereosinophilia and Hypereosinophilic Syndromes
Phase N/A · 1 location(s) · University Hospital, Lille · NCT04018118European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank
Phase N/A · 3 location(s) · Matthias Griese · NCT02852928Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biolog
Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06477653A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00091871Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders
Phase 2 · 4 location(s) · William Shomali · NCT03801434Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontroll
Phase 3 · 160 location(s) · AstraZeneca · NCT06750289The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangii
NA · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07275190A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy
Phase N/A · 28 location(s) · AstraZeneca · NCT07214753SIM0718 Treatment of Asthma Clinical Study
Phase 3 · 1 location(s) · Simcere Pharmaceutical Co., Ltd · NCT06488755Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
Phase 3 · 91 location(s) · GlaxoSmithKline · NCT05334368Myeloproliferative Neoplasms (MPNs) Patient Registry
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT02760238
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.